N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

N-Debenzoyl-N-[(3E)-hex-3-enoyl] Paclitaxel is an impurity of Paclitaxel (P132500); an antineoplastic. Used in the study of structure and function of microtubles into tubulin. Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi''s sarcoma. Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. Paclitaxel - Impurity Q.

N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-Debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxel Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11922	58
Moxin Chemicals	+8617320513646	mike@molcoo.com	China	9460	58
Guangzhou PI PI Biotech Inc	020-81716320 +86-13602409664	Sales@pipitech.com	China	3633	55
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	14055	65
ChemStrong Scientific Co.,Ltd	0755-0755-66853366 13670046396	sales@chem-strong.com	China	18070	56
Shanghai Yihe Biological Technology Co., Ltd.	17721395025	2423903095@qq.com	China	4066	58
Henan Alfachem Co.,Ltd.	0371-0371-55051623 18137891487	2853979817@qq.com	China	9908	58
Shenzhen Polymeri Biochemical Technology Co., Ltd.	+86-400-002-6226 +86-13028896684;	sales@rrkchem.com	China	57423	58
Shenzhen Botel Biotechnology Co. Ltd.	0755-22202135 13316968096	1979313431@qq.com	China	9020	58

---

• Paclitaxel EP Impurity Q
• Paclitaxel Impurity 17（Paclitaxel EP Impurity Q）
• Paclitaxel impurity 16/Paclitaxel EP Impurity Q/N-Debenzoyl-N-[(3E)-hex-3-enoyl] Paclitaxel/(αR,βS)-α-Hydroxy-β-[[(2E)-1-oxo-2-hexen-1-yl]amino]benzenepropanoic Acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9
• Paclitaxel EP Impurity Q N-debenzoyl-N-[(3E)-hex-3-enoyl]paclitaxe
• Benzenepropanoic acid, α-hydroxy-β-[[(2E)-1-oxo-2-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
• N-Debenzoyl-N-[(3E)-hex-3-enoyl] Paclitaxel
• (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-((E)-hex-2-enamido)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate
• (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12-(benzoyloxy)-9-(((2R,3S)-3-((E)-hex-2-enamido)-2-hydroxy-3-phenylpropanoyl)oxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-do
• 502626-06-4
• 243233-98-7